BNTC’s Financial Health: Exploring Benitec Biopharma Inc’s Debt-to-Equity Ratio of 1.79

Benitec Biopharma Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $17.15 on 06/10/25, while the lowest price for the same duration was marked at $5.74 on 06/21/24.

52-week price history of BNTC Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Benitec Biopharma Inc’s current trading price is -12.89% away from its 52-week high, while its distance from the 52-week low is 160.19%. The stock’s price range during the 52-week period has remained between $5.74 and $17.15. In the Healthcare sector, the company’s shares saw a trading volume of around 0.27 million for the day, which was evidently higher than the average daily volume of 52900.0 over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Benitec Biopharma Inc (BNTC) has experienced a quarterly decline of -4.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 392.17M and boasts a workforce of 16 employees.

Making Sense of Trading Volume and Moving Average Data

Examining BNTC’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BNTC stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.

BNTC Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a gain of 18.29%.However, over the last six months, we can see a weaker performance of 26.93%. Over the last 30 days, the price of BNTC has fallen by 6.87%. And in the last five days, it has fallen by -9.78%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.